NCT04325685View on ClinicalTrials.gov

The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

November 7, 2023

Conditions
Trauma InjuryBrain InjuriesAbdominal SepsisPancreatitisMeningitisEncephalitisSeizuresAcute Respiratory Distress Syndrome
Interventions
DRUG

Control

Oropharyngeal decontamination with saline will be performing three time a day every 8 hours during mechanical ventilation

DRUG

Antiseptic Solution

Oropharyngeal decontamination with antiseptic solution will be performing three time a day every 8 hours during mechanical ventilation

DRUG

Bacteriophage

Oropharyngeal decontamination with bacteriophage will be performing three time a day every 8 hours during mechanical ventilation

Trial Locations (1)

164500

"Budgetary Healthcare Institution of Arkhangelsk Region Severodvinsk City Clinical Emergency Hospital # 2", Severodvinsk

All Listed Sponsors
lead

Northern State Medical University

OTHER

NCT04325685 - The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia | Biotech Hunter | Biotech Hunter